1/35
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No analytics yet
Send a link to your students to track their progress
Female predominance
Higher prevalence in temperate climates
Young adult onset
Smoking
EBV exposure
Low vitamin D
Genetic predisposition
Female sex
Temperate climate residence
Optic neuritis
Weakness/numbness
Heat intolerance (Uhthoff phenomenon)
Sensory loss
Fatigue
Bladder dysfunction
Diplopia
Lhermitte’s sign
Ataxia
Afferent pupillary defect
Optic disc edema
Weakness
Hyperreflexia
Sensory deficits
CBC
BMP
ESR/CRP
B12
AMA
HIV
TSH w/ fT4
Lyme titers
Multiple hyperintense white matter plaques
Periventricular “Dawson’s fingers”
Juxtacortical, infratentorial, or spinal cord lesions
Oligoclonal bands indicating intrathecal IgG production.
Dissemination in space
Dissemination in time
Typical MRI lesions
Oligoclonal bands on LP
Treat acute relapses
Slow disease progression
Reduce relapse frequency
Manage symptoms
IV high‑dose glucocorticoids
Plasmapheresis
Interferon beta
Glatiramer acetate
Dimethyl fumarate/diroximel fumarate
Monoclonal antibodies (e.g., natalizumab, ocrelizumab)
PT
Amantadine for fatigue
Baclofen/tizanidine for spasticity
Oxybutynin for bladder dysfunction
Avoid heat exposure
Smoking cessation
Physical therapy
Occupational therapy
Progressive disability
Spasticity
Bladder dysfunction
Cognitive impairment
Depression
Mobility impairment
MRI for new lesions
Track relapse frequency
Monitor medication side effects
Evaluate functional status
Smoking cessation
Vitamin D optimization
Avoid overheating
IV high‑dose glucocorticoids
Interferon beta or glatiramer acetate
Plasmapheresis